LISUNAR Trademark

Trademark Overview

On Tuesday, May 13, 2008, a trademark application was filed for LISUNAR with the United States Patent and Trademark Office. The USPTO has given the LISUNAR trademark a serial number of 79053467. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, May 13, 2018. This trademark is owned by Actelion Pharmaceuticals Ltd.. The LISUNAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of neurological system diseases and disorders, and peripheral neurological system diseases and disorders, pharmaceutical preparations acting on the central nervous system, antiobesity, hypnotic sedatives, tranquilizing, neurotropic, anxiolytics, pharmaceutical preparations for the treatment of insomnia, addiction, eating disorders, and cognitive disorders
lisunar

General Information

Serial Number79053467
Word MarkLISUNAR
Filing DateTuesday, May 13, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, May 13, 2018
Registration Number3728489
Registration DateTuesday, December 22, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of neurological system diseases and disorders, and peripheral neurological system diseases and disorders, pharmaceutical preparations acting on the central nervous system, antiobesity, hypnotic sedatives, tranquilizing, neurotropic, anxiolytics, pharmaceutical preparations for the treatment of insomnia, addiction, eating disorders, and cognitive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameActelion Pharmaceuticals Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH-4123 Allschwil
CH
Party NameActelion Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4123 Allschwil
CH
Party NameActelion Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4123 Allschwil
CH

Trademark Events

Event DateEvent Description
Friday, December 14, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, December 14, 2018DEATH OF INTERNATIONAL REGISTRATION
Saturday, May 20, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, March 29, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, March 29, 2017INVALIDATION PROCESSED
Wednesday, March 29, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 29, 2016CANCELLED SECTION 71
Thursday, May 30, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 12, 2010FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 12, 2010FINAL DISPOSITION PROCESSED
Monday, March 22, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 22, 2009REGISTERED-PRINCIPAL REGISTER
Monday, November 30, 2009NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, November 12, 2009NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, November 12, 2009NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 6, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2009PUBLISHED FOR OPPOSITION
Tuesday, September 1, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 28, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 26, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 26, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 25, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 25, 2009TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 24, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 24, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 25, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 25, 2009FINAL REFUSAL E-MAILED
Wednesday, February 25, 2009FINAL REFUSAL WRITTEN
Tuesday, February 17, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 17, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 17, 2009ASSIGNED TO LIE
Friday, February 13, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 13, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, September 20, 2008REFUSAL PROCESSED BY IB
Tuesday, September 2, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 2, 2008REFUSAL PROCESSED BY MPU
Saturday, August 30, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 29, 2008NON-FINAL ACTION WRITTEN
Thursday, August 28, 2008ASSIGNED TO EXAMINER
Friday, June 13, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, June 12, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

lisunar disorders pharmaceutical preparations system diseases neurological treatment neurotropic anxiolytics insomnia